| Title | Author(s) | Year | View Count |
 | Impact of precore and core promoter mutations on hepatic histology in patients with chronic hepatitis B | Yuan, HJ; Yuen, MF; Wong, DKH; Sum, SM; Sablon, E; Ng, IOL; Lai, CL | 2005 | 95 |
 | Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance | Yuan, HJ; Yuen, MF; Wong, DKH; Sum, SM; Doutreloigne, J; Sablon, E; Lai, CL | 2005 | 249 |
| Hepatic necroinflammation and fibrosis in patients with genotypes Ba and C, core-promoter and precore mutations | Yuen, MF; Tanaka, Y; Ng, IOL; Mizokami, M; Yuen, JCH; Wong, DKH; Yuan, HJ; Sum, SM; Chan, AOO; Lai, CL | 2005 | 110 |
 | Comparison of the COBAS TaqMan HBV Test with the COBAS Amplicor Monitor Test for Measurement of Hepatitis B Virus DNA in Serum | Sum, SM; Wong, DKH; Yuen, JCH; Lai, CL; Yuen, RMF | 2005 | 90 |
| Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong | Yuen, MF; Sablon, E; Tanaka, Y; Kato, T; Mizokami, M; Doutreloigne, J; Yuan, HJ; Wong, DKH; Sum, SM; Lai, CL | 2004 | 103 |
| Longitudinal study of hepatitis activity and viral replication before and after HBeAg seroconversion in chronic hepatitis B patients infected with genotypes B and C | Yuen, MF; Fung, SK; Tanaka, Y; Kato, T; Mizokami, M; Yuen, JCH; Wong, DKH; Yuan, HJ; Sum, SM; Chan, AOO; Wong, BCY; Lai, CL | 2004 | 287 |
| HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infection | Yuen, MF; Wong, DKH; Yuan, HJ; Sum, SM; Lai, CL | 2004 | 273 |
| Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: A case control study | Yuen, MF; Tanaka, Y; Mizokami, M; Yuen, JCH; Wong, DKH; Yuan, HJ; Sum, SM; Chan, AOO; Wong, BCY; Lai, CL | 2004 | 134 |
| Quantitation of Covalently Closed Circular Hepatitis B Virus DNA in Chronic Hepatitis B Patients | Wong, DKH; Yuen, RMF; Yuan, H; Sum, SM; Hui, CK; Hall, J; Lai, CL | 2004 | 93 |
| Effect of lamivudine therapy on the serum covalently closed circular DNA of chronic hepatitis B infection. | Yuen, RMF; Wong, DKH; Sum, SM; Yuan, H; Yuen, JCH; Chan, OO; Wong, BCY; Lai, CL | 2004 | 55 |
| Quantitation of HBV covalently closed circular DNA (HBV cccDNA) in HCC patients. | Wong, DKH; Yuen, RMF; Poon, RTP; Sum, SM; Lai, CL | 2004 | 95 |
| Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine | Yuen, MF; Wong, DKH; Sablon, E; Yuan, HJ; Sum, SM; Hui, CK; Chan, AOO; Wong, BCY; Lai, CL | 2003 | 103 |
| Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations | Yuen, MF; Kato, T; Mizokami, M; Chan, AOO; Yuen, JCH; Yuan, HJ; Wong, DKH; Sum, SM; Ng, IOL; Fan, ST; Lai, CL | 2003 | 175 |
| A novel real-time PCR assay using molecular beacon (HBV Beacon Assay) for the quantitation of hepatitis B virus DNA | Sum, SM; Wong, DKH; Yuen, RMF; Yuan, H; Yu, J; Lai, CL; Zhang, L; Ho, D | 2003 | 169 |
| Hepatitis B virus genotypes B and C do not affect the anti-viral response to lamivudine | Yuen, RMF; Wong, DKH; Sablon, E; Yuan, H; Sum, SM; Hui, CK; Chan, AOO; Wong, BCY; Lai, CL | 2003 | 70 |
| Determinants for the Occurrence of Acute Exacerbation after HBeAg Seroclearance in Chinese Patients | Yuan, H; Yuen, MF; Wong, DKH; Sum, SM; Doutreloigne, J; Sablon, E; Lai, CL | 2003 | 84 |
| Determinants for the occurrence of acute exacerbation after HBeAg seroclearance in Chinese patients | Yuan, H; Yuen, RMF; Wong, DKH; Sum, SM; Doutreloigne, J; Sablon, E; Lai, CL | 2003 | 70 |
| Hepatitis B Virus Genotypes B and C Do Not Affect the Anti-viral Response to Lamivudine | Yuen, MF; Wong, DKH; Sablon, E; Yuan, H; Sum, SM; Hui, CK; Wong, BCY; Lai, CL | 2003 | 73 |
|
